אפופרוסטנול טבע ® 0.5 מ"ג

Pays: Israël

Langue: hébreu

Source: Ministry of Health

Ingrédients actifs:

EPOPROSTENOL AS SODIUM 0.5 MG

Disponible depuis:

SALOMON,LEVIN & ELSTEIN LTD

Code ATC:

B01AC09

forme pharmaceutique:

POWDER AND SOLVENT FOR SOLUTION FOR INFUSION

Mode d'administration:

I.V

Fabriqué par:

TEVA PARENTERAL MEDICINES INC, USA

Groupe thérapeutique:

EPOPROSTENOL

indications thérapeutiques:

Epoprostenol Teva is indicated for the long-term intravenous treatment of primary arterial pulmonary hypertension and arterial pulmonary hypertension associated with the scleroderma spectrum of disease in NYHA class III and class IV patients who do not respond to conventional therapy.

Date de l'autorisation:

2009-11-01